Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in heart transplant recipients with cardiac allograft vasculopathy
NCT00695344Phase 4Unknown
- Sponsor
- Fundación Universidad de Valladolid
- Start
- Jan 2006
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in cardiac allograft vasculopathy (CAV), sponsored by Fundación Universidad de Valladolid. Status: unknown.
02
Drugs
everolimus
03
Conditions
cardiac allograft vasculopathy (CAV)
Beyond the preview
Go deeper on NCT00695344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695344.